Chemoinformaics analysis of Cycloisolongifolene, 8,9-dehydro-9-formyl-
Molecular Weight | 230.351 | nRot | 1 |
Heavy Atom Molecular Weight | 208.175 | nRig | 0 |
Exact Molecular Weight | 230.167 | nRing | 5 |
Solubility: LogS | -8.113 | nHRing | 0 |
Solubility: LogP | 14.075 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 4 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 4 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 42.1914 |
nHD | 0 | BPOL | 22.9386 |
QED | 0.112 |
Synth | 2.161 |
Natural Product Likeliness | 0.359 |
NR-PPAR-gamma | 0.017 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -5.39 |
MDCK | 0.0000025 |
BBB | 0.003 |
PPB | 1.01854 |
VDSS | 5.365 |
FU | 0.0060803 |
CYP1A2-inh | 0.029 |
CYP1A2-sub | 0.121 |
CYP2c19-inh | 0.097 |
CYP2c19-sub | 0.053 |
CYP2c9-inh | 0.016 |
CYP2c9-sub | 0.973 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.008 |
CYP3a4-inh | 0.123 |
CYP3a4-sub | 0.013 |
CL | 4.376 |
T12 | 0.004 |
hERG | 0.495 |
Ames | 0.009 |
ROA | 0.01 |
SkinSen | 0.981 |
Carcinogencity | 0.012 |
EI | 0.921 |
Respiratory | 0.115 |
NR-Aromatase | 0.048 |
Antiviral | Yes |
Prediction | 0.78074 |